Practices

Israel

We Speak Your Language

Mintz Levin’s attorneys speak the language of the Israeli marketplace: entrepreneurial, innovative, bold, and determined. Our Israel Market Group offers Israeli clients, their investors, and their partners the best and brightest attorneys, ready to advance their international business activity. We know how important prompt, responsive, and cost-effective service is. Our attorneys’ business and legal savvy, experience, and commitment to the Israeli marketplace provide you with the highest level of counsel, representation, and attention.

Our Israel-focused industry teams combine our technical experience, industry knowledge, and understanding of the Israeli marketplace. From the intellectual property realm to the transactional, employment, immigration, and litigation fronts, we’re here to help you navigate the increasingly complex challenges of today’s competitive business environment.

Quick Facts

  • Full-service law firm
  • Recognized leader in serving technology companies and their investors
  • Long-lasting commitment to the Israeli marketplace
  • Liaison office in Herzelia Pituach facilitates easy and efficient collaboration and communications
  • Many years of experience delivering results for Israeli companies large and small
  • Commitment to build long-term success for clients
  • Among our clients: Teva, Comverse, NICE Systems, Rosetta Genomics, Elron, Medingo, Gamida Cell, iMDsoft

Mintz Levin and its attorneys are proudly  involved with organizations such as AIPAC, American Technion Society, Boston Israel Business Forum (BIBF), New England Israel Business Counsel (NEIBC), Israel Venture Network, and Tmura – the Israel Public Services Venture Fund.

Related Industries

1

News

1

1
1
1

1

Events

1

1
1
1

1



View all events

Publications

1

1
1
1

1

Resources

Current DevelopMintz

Center for Health Law & Policy
Bringing industry leaders, policy makers, and the best legal minds together to improve the health care system. >> Read more

Health Care Reform:
Analysis & Perspectives

>> Click here for details